CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious ...
This is a sample of The Echidna newsletter sent out each weekday morning. To sign up for FREE, go to theechidna.com.au ...
After hours: February 7 at 4:50:08 PM EST Loading Chart for FHTX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback